LTRX INVESTOR ALERT: Kirby McInerney LLP Reminds Lantronix, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the April 23, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ:LTRX) securities during the period of May 11, 2023 through February 8, 2024, inclusive (“the Class Period”).

[Click here to learn more about the class action]

In May 2023, Lantronix forecasted that it would achieve revenue in a range of $175 million to $185 million, as well as non-GAAP earnings-per-share (“EPS”) in a range of $0.50 to $0.60 per share, for its fiscal year 2024 results. The lawsuit alleges that the Company repeatedly assured investors and analysts throughout the Class Period that this guidance for fiscal year 2024 remained unchanged, despite knowing that Lantronix’s customers were experiencing elevated levels of inventory for internet of things (“IoT”) products.

On February 8, 2024, Lantronix issued a press release announcing its financial results for the second quarter of its fiscal year 2024. The Company negatively revised its fiscal year 2024 guidance, advising that “the company [now] expects revenue in a range of $155 million to $165 million” and “non-GAAP EPS in a range of $0.35 to $0.45 per share.” On a call with investors and analysts, Lantronix management explained the change as “primarily due to lower expected sales for our embedded IOT solutions as a result of two factors”, namely, “[a] general slowdown in our broad-based channel business as customers work through their inventories, and an embedded compute design win in video applications that was slated for revenue in the second half of fiscal 2024 that pushed into fiscal 2025.” On this news, the price of Lantronix shares declined by $1.89 per share, or approximately 32.5%, from $5.81 per share on February 8, 2024 to close at $3.92 on February 9, 2024.

The lawsuit alleges that throughout the Class Period, Lantronix made false and/or misleading statements and/or failed to disclose that: (i) Lantronix overstated demand and/or its visibility into demand for its IoT products; (ii) Lantronix's customers were reducing elevated levels of inventory of IoT products, thereby causing a general slowdown in the Company's business; (iii) certain of Lantronix’s embedded IoT revenues expected from a customer design win were delayed to the next fiscal year; (iv) as a result of all the foregoing, Lantronix anticipated lower sales for its embedded IoT solutions for fiscal year 2024; (v) accordingly, Lantronix was unlikely to meet its own previously issued guidance for fiscal year 2024; and (vi) as a result, the Company's public statements were materially false and/or misleading at all relevant times.

If you purchased or otherwise acquired Lantronix securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.